EP3078365A1 - Agents solubilisants et compositions aqueuses les comprenant - Google Patents
Agents solubilisants et compositions aqueuses les comprenant Download PDFInfo
- Publication number
- EP3078365A1 EP3078365A1 EP16164501.5A EP16164501A EP3078365A1 EP 3078365 A1 EP3078365 A1 EP 3078365A1 EP 16164501 A EP16164501 A EP 16164501A EP 3078365 A1 EP3078365 A1 EP 3078365A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- polyglyceryl
- glucoside
- caprate
- sodium
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CCCCCCCCCCCC(NC*)=O Chemical compound CCCCCCCCCCCC(NC*)=O 0.000 description 4
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q13/00—Formulations or additives for perfume preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/26—Optical properties
- A61K2800/262—Transparent; Translucent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/49—Solubiliser, Solubilising system
Definitions
- the present invention concerns new solubilizing agents, in particular new agents for solubilizing fatty phase(s) in aqueous compositions.
- the gemini surfactant is choosen from the group consisting of: poly(sodium decylglucoside hydroxypropylphosphate), poly(sodium laurylglucoside hydroxypropylphosphate), poly(sodium cocoylglucoside hydroxypropylphosphate and mixtures thereof).
- the gemini surfactant has the following formula (A'): wherein s is an integer comprised from 1 to 20, preferably from 1 to 5, and R' represents a linear or branched alkyl group comprising from 1 to 26 carbon atoms, preferably from 1 to 18, and more preferably from 1 to 12, carbon atoms.
- both R 5 and R 6 represent H.
- R 7 represents -(CH 2 ) 2 -COOX 1 , X 1 being as defined above.
- alkylpolyglucosides result from the condensation reaction of fatty alcohol(s) and of glucose or one of its derivatives.
- capryl/caprylyl glucoside results from the condensation reaction of a mixture of caprylic and decyl alcohols, with glucose.
- alkylpolyglucosides are blends of alkylpolyglucosides having different alkyl chain lengths, and/or having various degree of polymerization, namely various glucose (or glucose derivative) units.
- preferred alkylpolyglucosides are those in which R a consists:
- the fatty acid is selected from the group consisting of: caprylic acid, capric acid, oleic acid, lauric acid, myristic acid, ricinoleic acid, palmitic acid, stearic acid, arachidic acid, isostearic acid, behenic acid, and their mixtures.
- the polyglycerol fatty acid(s) ester according to the invention is selected from the group consisting of: polyglyceryl-4 caprylate/caprate, polyglyceryl-5 caprylate/caprate, polyglyceryl-6 caprylate/caprate, polyglyceryl-7 caprylate/caprate, polyglyceryl-8 caprylate/caprate, polyglyceryl-9 caprylate/caprate, polyglyceryl-10 caprylate/caprate, polyglyceryl-3 caprate, polyglyceryl-4 caprate, polyglyceryl-5 caprate, polyglyceryl-6 caprate, polyglyceryl-7 caprate, polyglyceryl-8 caprate, polyglyceryl-9 caprate, polyglyceryl-10 caprate, polyglyceryl-10 decastearate, polyglyceryl-3 diisostearate, polyglyceryl-10 diisostearate, polyglyceryl-4 laurate, polyglyceryl-5 laurate, polyglyceryl-6
- polyglycerol fatty acid(s) ester is polyglyceryl-6 laurate or polyglyceryl-4 caprate.
- polyglycerol fatty acid(s) ester is polyglyceryl-6 laurate commercialized under the trade name HEXAGLYN 1-L from NIKKOL or S-FACE L-601 from SAKAMOTO.
- composition according to the invention comprises a mixture of polyglyceryl-6 laurate and polyglyceryl-4 caprate.
- the composition according to the invention comprises from 1% to 60%, preferably from 2% to 50%, and more preferably from 5% to 40% by weight of polyglycerol fatty acid(s) ester(s), based on the total weight of the composition.
- the composition comprises from 15% to 40%, preferably from 20% to 30%, and more preferably from 25% to 30% by weight of polyglycerol fatty acid(s) ester(s), based on the total weight of the composition.
- the content of polyglycerol fatty acid(s) ester(s) in the composition according to the invention corresponds to the total content of polyglycerol fatty acid(s) ester(s) in said composition.
- the content of polyglycerol fatty acid(s) esters in the composition corresponds to the sum of the content of each polyglycerol fatty acid(s) ester in the composition.
- sugar fatty acid(s) ester means an ester of sugar and of at least one fatty acid.
- a sugar fatty acids ester is an ester of sugar and of a mixture of different fatty acids.
- the fatty acid is a linear or branched, saturated or unsaturated, carboxylic acid, comprising from 4 to 36 carbon atoms, preferably 4 to 22 carbon atoms, more preferably 6 to 12 carbon atoms.
- the composition according to the invention is alcohol-free.
- the solubilizing agent according to the invention is advantageously efficient at low concentrations for solubilizing fatty phase in aqueous compositions. This is particularly interesting in view of reducing, or even avoiding the impact of surfactants on skin, such as skin irritations...
- the vegetable oils are selected from the group consisting of: almond oil, apricot kernel oil, jojoba oil, argan oil, shear butter, grape seed oil, avocado oil, macadamia oil, sunflower oil, and mixture thereof.
- the aqueous composition C2 is a cosmetic composition.
- compositions were prepared as follows:
- compositions without sucrose laurate Compositions without sucrose laurate
- compositions A1 to A14 were prepared and are disclosed in the following table 1: Table 1 b: Compositions A15 to A20 X1 X2 X3 X4 X5 X6
- APG Caprylyl/Capryl Glucoside (60% by weight in water) 70% 70% 70% 70% 70% Polyglycerol fatty acid ester Polyglyceryl-4 Caprate 25% 25% 25% - - - Polyglyceryl-6 Laurate - - - 25% 25% 25% gemini Sodium dilauramidoglutamide lysine (29% by weight in water) 5% - - 5% - - Sodium bishydroxyethylglycinate Coco-glucosides crosspolymer (40% by weight in water) - 5% - 5% - - - - - 5% total 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%
- solubilizers A1 to A14 were compared with four commercialized surfactants for solubilizing a fatty phase in water: Solubilizer 1, Solubilizer 2, Solubilizer 3 and Solubilizer 4.
- compositions C3 to C26 were prepared according to the protocol disclosed in section B above. The percentages are % by weight relative to the total weight of the composition.
- compositions comprising only one ingredient
- compositions M1 to M14 are not efficient for solubilizing a fatty phase. Indeed, only emulsions (2 phases) or cloudy (not clear) compositions are obtained.
- compositions P1 to P21 are not efficient for solubilizing a fatty phase. Indeed, only emulsions (2 phases) or cloudy (not clear) compositions are obtained.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16164501.5A EP3078365B1 (fr) | 2015-04-10 | 2016-04-08 | Agents solubilisants et compositions aqueuses les comprenant |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15305534 | 2015-04-10 | ||
EP16164501.5A EP3078365B1 (fr) | 2015-04-10 | 2016-04-08 | Agents solubilisants et compositions aqueuses les comprenant |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3078365A1 true EP3078365A1 (fr) | 2016-10-12 |
EP3078365B1 EP3078365B1 (fr) | 2020-03-04 |
Family
ID=52875640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16164501.5A Active EP3078365B1 (fr) | 2015-04-10 | 2016-04-08 | Agents solubilisants et compositions aqueuses les comprenant |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3078365B1 (fr) |
DK (1) | DK3078365T3 (fr) |
ES (1) | ES2781424T3 (fr) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018090542A (ja) * | 2016-12-05 | 2018-06-14 | 日光ケミカルズ株式会社 | 可溶化剤 |
WO2020035245A1 (fr) | 2018-08-17 | 2020-02-20 | Beiersdorf Ag | Composition nettoyante |
DE102020206649A1 (de) | 2020-05-28 | 2021-12-02 | Henkel Ag & Co. Kgaa | Haarzusammensetzungen, umfassend ein glukosebasiertes haarkonditionierungsmittel und ein gemini-tensid |
KR102386119B1 (ko) * | 2021-08-06 | 2022-04-14 | 바이오스펙트럼 주식회사 | 피이지프리 천연 복합 가용화제 조성물 |
CN114948771A (zh) * | 2022-03-17 | 2022-08-30 | 广东丸美生物技术股份有限公司 | 一种含四氢姜黄素的组合物及其制备方法、护肤品 |
CN115151237A (zh) * | 2019-09-19 | 2022-10-04 | 化工产品开发公司Seppic | 具有良好喷雾特性的稳定加香组合物 |
CN115282076A (zh) * | 2022-07-28 | 2022-11-04 | 广州洁生日化有限公司 | 一种口腔护理清洁片及其制备方法及其使用方法 |
GB2606854A (en) * | 2021-04-15 | 2022-11-23 | Henkel Ag & Co Kgaa | Clear, skin-compatible deodorants or antiperspirants |
EP4349174A1 (fr) * | 2022-10-05 | 2024-04-10 | The Procter & Gamble Company | Composition antimicrobienne comprenant un glycoside d'alkyle modifié et un alcènediol |
US12090223B2 (en) | 2020-12-14 | 2024-09-17 | The Procter & Gamble Company | Method of manufacturing cosmetic compositions comprising sucrose esters and solvents |
US12171855B2 (en) | 2020-12-14 | 2024-12-24 | The Procter & Gamble Company | Cosmetic compositions comprising sucrose esters and solvents |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3127399B1 (fr) * | 2021-09-30 | 2025-01-10 | Oreal | Emulsion H/E avec C-glycoside et tensioactifs spécifiques |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5789371A (en) * | 1997-04-22 | 1998-08-04 | Rhodia Inc. | Amphoteric surfactants having multiple hydrophobic and hydrophilic groups |
WO2005039642A1 (fr) * | 2003-10-24 | 2005-05-06 | University Of Saskatchewan | Apport d'adn utilisant des tensioactifs cationiques gemines |
US20140121174A1 (en) * | 2012-10-25 | 2014-05-01 | Henkel Ag & Co. Kgaa | Anti-dandruff hair care products with selective active ingredients and a cationic keratin |
WO2014076136A1 (fr) * | 2012-11-13 | 2014-05-22 | Galderma S.A. | Composition d'emulsion de lavage au bpo |
WO2015054135A1 (fr) * | 2013-10-07 | 2015-04-16 | Presperse Corporation | Compositions à phase interne élevée renfermant un tensioactif gemini |
-
2016
- 2016-04-08 DK DK16164501.5T patent/DK3078365T3/da active
- 2016-04-08 EP EP16164501.5A patent/EP3078365B1/fr active Active
- 2016-04-08 ES ES16164501T patent/ES2781424T3/es active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5789371A (en) * | 1997-04-22 | 1998-08-04 | Rhodia Inc. | Amphoteric surfactants having multiple hydrophobic and hydrophilic groups |
WO2005039642A1 (fr) * | 2003-10-24 | 2005-05-06 | University Of Saskatchewan | Apport d'adn utilisant des tensioactifs cationiques gemines |
US20140121174A1 (en) * | 2012-10-25 | 2014-05-01 | Henkel Ag & Co. Kgaa | Anti-dandruff hair care products with selective active ingredients and a cationic keratin |
WO2014076136A1 (fr) * | 2012-11-13 | 2014-05-22 | Galderma S.A. | Composition d'emulsion de lavage au bpo |
WO2015054135A1 (fr) * | 2013-10-07 | 2015-04-16 | Presperse Corporation | Compositions à phase interne élevée renfermant un tensioactif gemini |
Non-Patent Citations (15)
Title |
---|
CASTRO M J L ET AL: "SYNERGISTIC EFFECTS OF ALKYL GLUCOSIDES AND NONIONIC SUGAR-BASED GEMINI SURFACTANTS//SYNERGISTISCHE EFFEKTE VON ALKYLGLUCOSIDEN UND NICHTIONISCHEN GEMINI-ZUCHERTENSIDEN", TENSIDE, SURFACTANTS, DETERGENTS, CARL HANSER VERLAG, MUNCHEN, DE, vol. 39, no. 2, 1 February 2002 (2002-02-01), pages 28 - 30, XP001112743, ISSN: 0932-3414 * |
DATABASE GNPD [online] MINTEL; 1 November 2014 (2014-11-01), ANONYMOUS: "GNPD - Active Surge Eye Cream", XP055213131, retrieved from Mintel accession no. 2769661 Database accession no. 2769661 * |
GAO ET AL., JAOCS, vol. 71, no. 7, July 1994 (1994-07-01), pages 771 |
GRIFFIN WC: "Calculation of HLB Values of Non-lonic Surfactants", JOURNAL OF THE SOCIETY OF COSMETIC CHEMISTS, vol. 5, 1954, pages 259 |
GRIFFIN WC: "Classification of Surface- Active Agents by 'HLB", JOURNAL OFTHE SOCIETY OF COSMETIC CHEMISTS, vol. 1, 1949, pages 311 |
MASUYAMA ET AL., 41 J. JAPAN CHEM. SOC., vol. 4, 1992, pages 301 |
MENGER ET AL., J. AM. CHEM. SOC., vol. 115, no. 2, 1993, pages 10083 |
MENGER ET AL., J. AM. CHEMICAL SOC., vol. 113, 1991, pages 1451 |
OKAHARA ET AL., J. JAPAN OIL CHEM. SOC., 1989, pages 746 |
ROSEN M J: "GEMINIS: A NEW GENERATION OF SURFACTANTS", CHEMTECH, WASHINGTON, DC, US, 1 March 1993 (1993-03-01), pages 30 - 33, XP000645619, ISSN: 0009-2703 * |
ROSEN, CHEMTECH, March 1993 (1993-03-01), pages 30 |
ZHU ET AL., 68 JAOCS, vol. 7, 1991, pages 539 |
ZHU ET AL., JAOCS, vol. 67, no. 7, July 1990 (1990-07-01), pages 459 |
ZHU ET AL., JAOCS, vol. 69, no. 1, January 1992 (1992-01-01), pages 30 |
ZHU ET AL., JAOCS, vol. 69, no. 7, July 1992 (1992-07-01), pages 626 |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018090542A (ja) * | 2016-12-05 | 2018-06-14 | 日光ケミカルズ株式会社 | 可溶化剤 |
WO2020035245A1 (fr) | 2018-08-17 | 2020-02-20 | Beiersdorf Ag | Composition nettoyante |
CN115151237A (zh) * | 2019-09-19 | 2022-10-04 | 化工产品开发公司Seppic | 具有良好喷雾特性的稳定加香组合物 |
DE102020206649A1 (de) | 2020-05-28 | 2021-12-02 | Henkel Ag & Co. Kgaa | Haarzusammensetzungen, umfassend ein glukosebasiertes haarkonditionierungsmittel und ein gemini-tensid |
US12171855B2 (en) | 2020-12-14 | 2024-12-24 | The Procter & Gamble Company | Cosmetic compositions comprising sucrose esters and solvents |
US12090223B2 (en) | 2020-12-14 | 2024-09-17 | The Procter & Gamble Company | Method of manufacturing cosmetic compositions comprising sucrose esters and solvents |
GB2606854B (en) * | 2021-04-15 | 2023-09-06 | Henkel Ag & Co Kgaa | Clear, skin-compatible PEG-free deodorants or antiperspirants |
GB2606854A (en) * | 2021-04-15 | 2022-11-23 | Henkel Ag & Co Kgaa | Clear, skin-compatible deodorants or antiperspirants |
KR102386119B1 (ko) * | 2021-08-06 | 2022-04-14 | 바이오스펙트럼 주식회사 | 피이지프리 천연 복합 가용화제 조성물 |
CN114948771A (zh) * | 2022-03-17 | 2022-08-30 | 广东丸美生物技术股份有限公司 | 一种含四氢姜黄素的组合物及其制备方法、护肤品 |
CN115282076B (zh) * | 2022-07-28 | 2023-06-27 | 广州洁生日化有限公司 | 一种口腔护理清洁片及其制备方法及其使用方法 |
CN115282076A (zh) * | 2022-07-28 | 2022-11-04 | 广州洁生日化有限公司 | 一种口腔护理清洁片及其制备方法及其使用方法 |
EP4349174A1 (fr) * | 2022-10-05 | 2024-04-10 | The Procter & Gamble Company | Composition antimicrobienne comprenant un glycoside d'alkyle modifié et un alcènediol |
Also Published As
Publication number | Publication date |
---|---|
ES2781424T3 (es) | 2020-09-02 |
EP3078365B1 (fr) | 2020-03-04 |
DK3078365T3 (da) | 2020-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3078365B1 (fr) | Agents solubilisants et compositions aqueuses les comprenant | |
JP2023552848A (ja) | 1種または複数の(バイオ)アルカンジオールおよび活性成分を含む組成物 | |
WO2013092080A1 (fr) | Produit pour le soin du corps avec hydratation dermique améliorée | |
FR3015246A1 (fr) | Composition cosmetique comprenant une huile, un tensioactif non ionique et un compose c-glycoside | |
ES2587337T3 (es) | Composiciones cosméticas que contienen ésteres a base de 2-etilbutanol | |
EP3082754B1 (fr) | Utilisation d'alkylpolyglycosides comme solubilisants de parfums et composition parfumante les comprenant | |
US8183298B2 (en) | Fatty acid esters, processes for their production and for incorporation into cosmetic and/or pharmaceutical formulations | |
US12251457B2 (en) | Self-neutralizing amino acid based cationic compositions | |
EP1212033B1 (fr) | Composition cosmetique | |
EP0821936A2 (fr) | Combinaisons de substances actives déodorantes à base d'acides de lanoline, de glycerides partiels et de combinaisons aryles | |
US20230081952A1 (en) | Cleansing composition | |
EP0709082A2 (fr) | Combinations des agents à base des acides de cire de laine et glycérides des acides gras saturés efficace contre la peau impure, des formes légères d'acné et propionibactérium acnés | |
ES2561160T5 (es) | Preparaciones cosméticas que contienen ésteres a base de 2-butiloctanol | |
US20220135769A1 (en) | Biobased glyceryl heptanoate ester compositions and methods of making and using the same | |
US7875653B2 (en) | Emulsion comprising 1,2-alkanediols and polar oil components | |
EP1704898A1 (fr) | Composition cosmétique protégée de l'oxydation par de l'huile de germe de riz | |
WO2020122087A1 (fr) | Composition d'émulsion huile dans eau comprenant une huile d'éther | |
KR102532929B1 (ko) | 피부 화장료용 조성물 | |
ES2390631T3 (es) | Composiciones cosméticas que contienen ésteres a base de ácido 2-propilheptanoico | |
JP7403299B2 (ja) | オイルゲル組成物および化粧料 | |
FR3120793A1 (fr) | Agents solubilisants et compositions les comprenant | |
JP6106777B2 (ja) | 皮膚外用剤 | |
JP7142138B2 (ja) | 難水溶性成分の溶解性を向上させる方法 | |
WO2019044529A1 (fr) | Composition à émulsion de type aqueux comprenant une huile d'éther | |
US20230355494A1 (en) | Shaving composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20170313 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20180523 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20190924 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: CH Ref legal event code: NV Representative=s name: MICHELI AND CIE SA, CH |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1239560 Country of ref document: AT Kind code of ref document: T Effective date: 20200315 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602016030904 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 Effective date: 20200430 |
|
REG | Reference to a national code |
Ref country code: FI Ref legal event code: FGE |
|
REG | Reference to a national code |
Ref country code: EE Ref legal event code: FG4A Ref document number: E018884 Country of ref document: EE Effective date: 20200325 |
|
REG | Reference to a national code |
Ref country code: GR Ref legal event code: EP Ref document number: 20200401169 Country of ref document: GR Effective date: 20200615 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200604 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200304 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20200518 Year of fee payment: 5 Ref country code: EE Payment date: 20200320 Year of fee payment: 5 Ref country code: GR Payment date: 20200508 Year of fee payment: 5 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20200304 |
|
REG | Reference to a national code |
Ref country code: EE Ref legal event code: HC1A Ref document number: E018884 Country of ref document: EE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200304 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200304 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200304 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200604 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2781424 Country of ref document: ES Kind code of ref document: T3 Effective date: 20200902 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200304 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200729 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200304 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200304 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200304 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200304 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200304 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200704 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20200821 Year of fee payment: 5 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1239560 Country of ref document: AT Kind code of ref document: T Effective date: 20200304 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602016030904 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200304 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200408 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200304 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20200430 |
|
26N | No opposition filed |
Effective date: 20201207 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200430 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200304 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200304 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FI Payment date: 20210322 Year of fee payment: 6 |
|
REG | Reference to a national code |
Ref country code: EE Ref legal event code: MM4A Ref document number: E018884 Country of ref document: EE Effective date: 20210430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20211108 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210408 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200304 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200304 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200304 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200304 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200304 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20220630 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210409 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220408 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DK Payment date: 20230327 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20230502 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240327 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240425 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240409 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20240409 Year of fee payment: 9 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP Effective date: 20240430 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20240430 |